Prescription drug · NDA
Propecia (finasteride) NDC 78206-152
Finasteride 1 mg/1 · Tablet, Film coated · Oral · Organon LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 78206-152-01 | 78206015201 | 30 TABLET, FILM COATED in 1 BOTTLE (78206-152-01)Marketed from Jun 1, 2021 | |
| 78206-152-02 | 78206015202 | 90 TABLET, FILM COATED in 1 BOTTLE (78206-152-02)Marketed from Jun 1, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Propecia
- Generic name (nonproprietary)
- finasteride
- Active ingredients
- Finasteride — 1 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Organon LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020788
- Marketing start
- Listing expires
- Other FDA classes
- 5-alpha Reductase Inhibitors (Mechanism)
- Identifiers
- Product ID 78206-152_97f5deb0-a4ab-42c3-afa0-db2170a16297SPL ID 97f5deb0-a4ab-42c3-afa0-db2170a16297SPL set ID 6f904709-65aa-44ce-b144-b4c8a0416e36RxCUI 200172, 213178UNII 57GNO57U7GUPC 0378206152015
- Pharmacologic class
- 5-alpha Reductase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N478206015201followed by a unit qualifier and the quantityPackage 78206-0152-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PROPECIA ® is indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY . Efficacy in bitemporal recession has not been established. PROPECIA is not indicated for use in women. PROPECIA is a 5α-reductase inhibitor indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY ( 1 ). PROPECIA is not indicated for use in women ( 1 , 4 , 5.1 ).
Excerpt only. Read the full label for complete information.